Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced the appointment ...

Large cohort study finds increased cognitive impairment risk in rheumatoid arthritis, supporting routine cognitive screening ...

Rheumatoid Arthritis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape The rheumatoid arthritis ...

Physical activity is now a central part of arthritis and osteoarthritis care according to updated EULAR guidelines. Read more ...

Lovell Government Services and SetPoint Medical partner to deliver FDA-approved neuroimmune therapy for rheumatoid ...

Prefilled syringes (PFS) preferred on pharmacy benefit; vials preferred on medical benefit RALEIGH, N.C., April 20, 2026 /PRNewswire/ -- Accord BioPharma, the U.S. specialty division of Intas ...

Scientists, health care professionals, patients, researchers, fellows, supporters and many others joined us in Washington, D.C., for several events we hosted during the American College of ...

A newly discovered strategy interrupts a key molecular process that drives chronic inflammation while preserving normal immune defenses. Credit: Shutterstock Researchers have identified a promising ...

aDepartment of Orthopedics, Xiangya Hospital, Central South University, Hunan, China bNational Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, ...

One of the most common and debilitating conditions affecting older adults may soon be far more treatable. Scientists have developed several potentially groundbreaking therapies for knee osteoarthritis ...

Good news: Scientists may be closer to a new way to treat arthritis. The Advanced Research Projects Agency for Health (ARPA-H) said several experimental treatments could help regrow cartilage and bone ...